• Skip to main content
  • Skip to primary sidebar

Tracking Health and Wellness Applications of Brain Science

Spanish
sb-logo-with-brain
  • Resources
    • Monthly eNewsletter
    • Solving the Brain Fitness Puzzle
    • The SharpBrains Guide to Brain Fitness
    • How to evaluate brain training claims
    • Resources at a Glance
  • Brain Teasers
    • Top 25 Brain Teasers & Games for Teens and Adults
    • Brain Teasers for each Cognitive Ability
    • More Mind Teasers & Games for Adults of any Age
  • Virtual Summits
    • 2019 SharpBrains Virtual Summit
    • Speaker Roster
    • Brainnovations Pitch Contest
    • 2017 SharpBrains Virtual Summit
    • 2016 SharpBrains Virtual Summit
    • 2015 SharpBrains Virtual Summit
    • 2014 SharpBrains Virtual Summit
  • Report: Pervasive Neurotechnology
  • Report: Digital Brain Health
  • About
    • Mission & Team
    • Endorsements
    • Public Speaking
    • In the News
    • Contact Us

Machine-learning study finds EEG brain signatures that predict response to antidepressant treatments

February 18, 2020 by SharpBrains

–

Brain-wave pat­tern can iden­ti­fy peo­ple like­ly to respond to anti­de­pres­sant, study finds (Stan­ford Med­i­cine press release):

“A new method of inter­pret­ing brain activ­i­ty could poten­tial­ly be used in clin­ics to help deter­mine the best treat­ment options for depres­sion, accord­ing to a study led by researchers at the Stan­ford School of Medicine.

Stan­ford researchers and their col­lab­o­ra­tors used elec­troen­cephalog­ra­phy, a tool for mon­i­tor­ing elec­tri­cal activ­i­ty in the brain, and an algo­rithm to iden­ti­fy a brain-wave sig­na­ture in indi­vid­u­als with depres­sion who will most like­ly respond to ser­tra­line, an anti­de­pres­sant mar­ket­ed as Zoloft …

“This study takes pre­vi­ous research show­ing that we can pre­dict who ben­e­fits from an anti­de­pres­sant and actu­al­ly brings it to the point of prac­ti­cal util­i­ty,” said Amit Etkin, MD, PhD, pro­fes­sor of psy­chi­a­try and behav­ioral sci­ences at Stan­ford. “I will be sur­prised if this isn’t used by clin­i­cians with­in the next five years.”

Instead of func­tion­al mag­net­ic res­o­nance imag­ing, an expen­sive tech­nol­o­gy often used in stud­ies to image brain activ­i­ty, the sci­en­tists turned to elec­troen­cephalog­ra­phy, or EEG, a much less cost­ly technology…

The paper is one of sev­er­al based on data from a fed­er­al­ly fund­ed depres­sion study launched in 2011 — the largest ran­dom­ized, place­bo-con­trolled clin­i­cal tri­al on anti­de­pres­sants ever con­duct­ed with brain imag­ing — which test­ed the use of ser­tra­line in 309 med­ica­tion-free patients. The mul­ti­cen­ter tri­al was called Estab­lish­ing Mod­er­a­tors and Biosig­na­tures of Anti­de­pres­sant Response for Clin­i­cal Care, or EMBARC. Led by Trive­di, it was designed to advance the goal of improv­ing the tri­al-and-error method of treat­ing depres­sion that is still in use today.

“It often takes many steps for a patient with depres­sion to get bet­ter,” Trive­di said. “We went into this think­ing, ‘Wouldn’t it be bet­ter to iden­ti­fy at the begin­ning of treat­ment which treat­ments would be best for which patients?’”

The Study:

An elec­troen­cephalo­graph­ic sig­na­ture pre­dicts anti­de­pres­sant response in major depres­sion (Nature Biotechnology)

  • Abstract: Anti­de­pres­sants are wide­ly pre­scribed, but their effi­ca­cy rel­a­tive to place­bo is mod­est, in part because the clin­i­cal diag­no­sis of major depres­sion encom­pass­es bio­log­i­cal­ly het­ero­ge­neous con­di­tions. Here, we sought to iden­ti­fy a neu­ro­bi­o­log­i­cal sig­na­ture of response to anti­de­pres­sant treat­ment as com­pared to place­bo. We designed a latent-space machine-learn­ing algo­rithm tai­lored for rest­ing-state elec­troen­cephalog­ra­phy (EEG) and applied it to data from the largest imag­ing-cou­pled, place­bo-con­trolled anti­de­pres­sant study (n?=?309). Symp­tom improve­ment was robust­ly pre­dict­ed in a man­ner both spe­cif­ic for the anti­de­pres­sant ser­tra­line (ver­sus place­bo) and gen­er­al­iz­able across dif­fer­ent study sites and EEG equip­ment. This ser­tra­line-pre­dic­tive EEG sig­na­ture gen­er­al­ized to two depres­sion sam­ples, where­in it reflect­ed gen­er­al anti­de­pres­sant med­ica­tion respon­siv­i­ty and relat­ed dif­fer­en­tial­ly to a repet­i­tive tran­scra­nial mag­net­ic stim­u­la­tion treat­ment out­come. Fur­ther­more, we found that the ser­tra­line rest­ing-state EEG sig­na­ture indexed pre­frontal neur­al respon­siv­i­ty, as mea­sured by con­cur­rent tran­scra­nial mag­net­ic stim­u­la­tion and EEG. Our find­ings advance the neu­ro­bi­o­log­i­cal under­stand­ing of anti­de­pres­sant treat­ment through an EEG-tai­lored com­pu­ta­tion­al mod­el and pro­vide a clin­i­cal avenue for per­son­al­ized treat­ment of depression.

The Study in Context:

  • Should Cog­ni­tive Behav­iour­al Ther­a­py (not anti­de­pres­sant drugs) be the first-line treat­ment for depression?
  • Neu­ro­engi­neer­ing meets neu­roethics to address treat­ment-resis­tant depression
  • CVS Health: Cog­ni­tive behav­ioral ther­a­py (CBT) apps may help you more than sleep­ing pills
  • A call to action: We need the right incen­tives to guide eth­i­cal inno­va­tion in neu­rotech and healthcare
  • New report: Empow­er­ing 8 Bil­lion Minds via Eth­i­cal Devel­op­ment and Adop­tion of Neurotechnologies
  • 10 high­lights from the 2019 Sharp­Brains Vir­tu­al Summit

Rethink­ing and Retool­ing Brain Health and Men­tal Health from Sharp­Brains

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, Technology & Innovation Tagged With: algorithm, Amit Etkin, antidepressant, antidepressants, brain, brain-activity, brain-wave signature, depression, depression-treatment, EEG, electrical activity, electroencephalography, fMRI, functional magnetic resonance imaging, neurobiological, sertraline, Stanford, treatment, Zoloft

Primary Sidebar

Top Articles on Brain Health and Neuroplasticity

  1. Can you grow your hippocampus? Yes. Here’s how, and why it matters
  2. How learning changes your brain
  3. To harness neuroplasticity, start with enthusiasm
  4. Three ways to protect your mental health during –and after– COVID-19
  5. Why you turn down the radio when you're lost
  6. Solving the Brain Fitness Puzzle Is the Key to Self-Empowered Aging
  7. Ten neu­rotech­nolo­gies about to trans­form brain enhance­ment & health
  8. Five reasons the future of brain enhancement is digital, pervasive and (hopefully) bright
  9. What Educators and Parents Should Know About Neuroplasticity and Dance
  10. The Ten Habits of Highly Effective Brains
  11. Six tips to build resilience and prevent brain-damaging stress
  12. Can brain training work? Yes, if it meets these 5 conditions
  13. What are cognitive abilities and how to boost them?
  14. Eight Tips To Remember What You Read
  15. Twenty Must-Know Facts to Harness Neuroplasticity and Improve Brain Health

Top 10 Brain Teasers and Illusions

  1. You think you know the colors? Try the Stroop Test
  2. Check out this brief attention experiment
  3. Test your stress level
  4. Guess: Are there more brain connections or leaves in the Amazon?
  5. Quick brain teasers to flex two key men­tal mus­cles
  6. Count the Fs in this sentence
  7. Can you iden­tify Apple’s logo?
  8. Ten classic optical illu­sions to trick your mind
  9. What do you see?
  10. Fun Mental Rotation challenge
  • Check our Top 25 Brain Teasers, Games and Illusions

Join 35,205 readers exploring, at no cost, the latest in neuroplasticity and brain health.

By subscribing you agree to receive our free, monthly eNewsletter. We don't rent or sell emails collected, and you may unsubscribe at any time.

IMPORTANT: Please check your inbox or spam folder in a couple minutes and confirm your subscription.

Get In Touch!

Contact Us

660 4th Street, Suite 205,
San Francisco, CA 94107 USA

About Us

SharpBrains is an independent market research firm tracking health and performance applications of brain science. We prepare general and tailored market reports, publish consumer guides, produce an annual global and virtual conference, and provide strategic advisory services.

© 2022 SharpBrains. All Rights Reserved - Privacy Policy